Corcept Therapeutics
CORT
#2296
Rank
A$11.87 B
Marketcap
A$108.50
Share price
3.10%
Change (1 day)
-6.60%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2023 (TTM): A$1.33

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is A$0.75. In 2022 the company made an earnings per share (EPS) of A$1.37 a decrease over its 2021 EPS that were of A$1.40.

EPS history for Corcept Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$1.33-3.06%
2022A$1.37-2.06%
2021A$1.405.43%
2020A$1.3310.84%
2019A$1.2027.69%
2018A$0.94-42.48%
2017A$1.631518.29%
2016A$0.10-199.75%
2015A-$0.10-77.42%
2014A-$0.45-32.61%
2013A-$0.6712.2%
2012A-$0.592.5%
2011A-$0.582.56%
2010A-$0.562.63%
2009A-$0.55-11.63%
2008A-$0.6226.47%
2007A-$0.49-68.81%
2006A-$1.5823.86%
2005A-$1.27-1.12%
2004A-$1.29-27.05%
2003A-$1.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.67 1,185.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.59 909.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.10 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.64 5,835.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.44 90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.54 769.23%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A-$0.19-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.02892-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA